Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Injecting specific cells into the skin can help improve skin structure and reduce blisters in a genetic skin disorder.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Anti-aging peptides can improve skin appearance but need better delivery methods and more research.

Caregiver perspective-taking affects stress hormone levels in people with Alzheimer's.

Homeopathy helped a man regrow hair and feel better from total hair loss.

Open discussions and treatment options for hair loss can boost confidence and reduce distress in young men.

Scalp hair follicle cells help protect and heal skin in certain skin conditions.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Accurate diagnosis of RDEB-mitis in older adults is crucial for proper management without immunosuppressants.

Scientists created cell lines to study a genetic skin disorder using CRISPR technology.

Most Recessive Dystrophic Epidermolysis Bullosa patients with a specific mutation likely have Sephardic ancestry from about 500 years ago.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

CRH promotes fat production in skin cells, affecting conditions like acne.

Mutations in the P2RY5 gene cause autosomal recessive woolly hair.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

The skin produces and responds to thyroid-stimulating hormone, which is controlled by other thyroid-related hormones.

Mutations in the DSG4 gene cause a severe form of brittle hair and skin issues.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

TRH stimulates human hair growth and extends the hair growth phase.

New mutations in the hairless gene may cause hair loss and affect bone development.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Olmsted syndrome can be inherited as an autosomal recessive trait due to a rare TRPV3 gene mutation.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

A new mutation in the ST14 gene was found in a patient with ARIH syndrome, showing milder symptoms and no tooth issues.

A mutation in the KRT25 gene causes a rare hair disorder with thin, woolly hair.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.